Ignite Creation Date:
2025-12-24 @ 2:48 PM
Ignite Modification Date:
2025-12-27 @ 8:14 PM
Study NCT ID:
NCT07101159
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-08-03
First Post:
2025-07-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients
Sponsor:
Fujian Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2031-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-12
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-25
First Submit QC Date:
None
Study First Post Date:
2025-08-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-01
Last Update Post Date:
2025-08-03
Last Update Post Date Type:
ACTUAL